Journal article
Oral Anticoagulant Therapy in Patients with Coronary Artery Disease
Abstract
Oral anticoagulation (OA) has been used to treat patients with coronary artery disease (CAD) for more than 40 years and has been a subject of intense controversy since that time. Seven to 10% of patients with acute myocardial infarction (MI) develop recurrent MI, stroke, or death in the 6 weeks following the index event and approximately 20% after 4 years, despite optimal background therapy with aspirin. Recent large studies and systematic …
Authors
Hackam D; Anand S; Yusuf S
Journal
Seminars in Thrombosis and Hemostasis, Vol. 03, No. 3, pp. 323–332
Publisher
Thieme
Publication Date
2003
DOI
10.1055/s-2003-44468
ISSN
0094-6176